Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. That said, here is one stock where Wall Street’s positive outlook is supported by strong fundamentals and two where analysts may be overlooking some important risks.
Two Stocks to Sell:
LeMaitre (LMAT)
Consensus Price Target: $107 (32.1% implied return)
Founded in 1983 and named after a pioneering vascular surgeon, LeMaitre Vascular (NASDAQGM:LMAT) develops and manufactures specialized medical devices used by vascular surgeons to treat peripheral vascular disease and other circulatory conditions.
Why Do We Think Twice About LMAT?
- Subscale operations are evident in its revenue base of $262.4 million, meaning it has fewer distribution channels than its larger rivals
LeMaitre’s stock price of $81.01 implies a valuation ratio of 25.8x forward P/E. Check out our free in-depth research report to learn more about why LMAT doesn’t pass our bar.
Equifax (EFX)
Consensus Price Target: $206.33 (42.8% implied return)
Holding detailed financial records on over 800 million consumers worldwide and dating back to 1899, Equifax (NYSE:EFX) is a global data analytics company that collects, analyzes, and sells consumer and business credit information to lenders, employers, and other businesses.
Why Is EFX Not Exciting?
- Efficiency has decreased over the last five years as its adjusted operating margin fell by 3.6 percentage points
- Earnings per share lagged its peers over the last five years as they only grew by 1.1% annually
Equifax is trading at $144.54 per share, or 15.3x forward P/E. Dive into our free research report to see why there are better opportunities than EFX.
One Stock to Buy:
TransDigm (TDG)
Consensus Price Target: $1,484 (35.8% implied return)
Supplying parts for nearly all aircraft currently in service, TransDigm (NYSE:TDG) develops and manufactures components and systems for military and commercial aviation.
Why Are We Bullish on TDG?
- Average organic revenue growth of 9.3% over the past two years demonstrates its ability to expand independently without relying on acquisitions
- Share buybacks catapulted its annual earnings per share growth to 29.9%, which outperformed its revenue gains over the last five years
- Robust free cash flow margin of 20% gives it many options for capital deployment, and its rising cash conversion increases its margin of safety
At $1,093 per share, TransDigm trades at 23.7x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.